Study to Assess the Efficacy and Safety of Raxone in LHON Patients

NCT02774005 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Leber's Hereditary Optic Neuropathy (LHON)

Interventions

DRUG: Idebenone

Sponsor

Santhera Pharmaceuticals